A flicker of light for the treatment of Alzheimer’s

  • 📰 TheEconomist
  • ⏱ Reading Time:
  • 7 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 92%

United States Headlines News

United States Latest News,United States Headlines

On “Babbage” with kncukier: -simonlong55 on whether the FDA’s gamble on a new Alzheimer’s drug will pay off -How to make fog-collecting devices more effective -The life-saving potential of oxygen enemas

Our podcast on the science and technology making the news. Also this week: fog-collecting innovation, and the promise of oxygen enemas.

Our podcast on the science and technology making the news. Also this week: fog-collecting innovation, and the promise of oxygen enemas

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

kncukier simonlong55 Conditional approval does not exist in the US.

kncukier simonlong55 June12Protest June12Protest June12Protest June12Protest June12Protest

kncukier simonlong55 New drug found not to work. 3 of expert panel that voted (9-1) against approving this drug have resigned in protest of the FDA decision. Corruption or money changing hands must be at the core of the FDA decision. Investigative journo needed.

kncukier simonlong55 Pls let stand for 🇳🇬KeepitOn EndBadGoveranceInNigeria June12thProtest please the world know

kncukier simonlong55 A real loser of a drug. Not worth the hype

kncukier simonlong55 They will die a slow death naturally from alzheimers so what would be the negative outcome of trying this medication?

kncukier simonlong55 $sava

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

The long road to approval of controversial Alzheimer's treatment from BiogenThe U.S. Food and Drug Administration on Monday approved the first treatment of Alzheimer's disease in nearly two decades, Biogen Inc's (BIIB.O) aducanumab, after a long development process including one large trial that failed to meet its goal.
Source: Reuters - 🏆 2. / 97 Read more »

US approves first new Alzheimer's drug in two decadesUS Food and Drug Administration said that the drug developed by Biogen named Aducanumab, or Aduhelm, is the only one that can likely treat the underlying disease as independent advisers urge caution over the treatment.
Source: trtworld - 🏆 101. / 63 Read more »

FDA Approves Controversial Alzheimer's DrugThe FDA has approved a controversial new drug for the treatment of Alzheimer's disease, ignoring the recommendation by its own advisory panel to reject it. $$$$$$ Noice So that means all Alzheimers patients will become human guinea pigs!
Source: WebMD - 🏆 709. / 51 Read more »

New Alzheimer’s drug is 1st of its kind to be FDA approvedJUST IN: In a major development for patients and the biotechnology industry, the FDA approves the use of a new drug, aducanumab, for treating early Alzheimer’s disease. anacpretto Magic 🍄 treats/cures as well. And it's free Unfortunate it was given a name that’s hard to remember.
Source: ABC - 🏆 471. / 51 Read more »

FDA approves controversial Alzheimer’s drug – 1st therapy approved since 2003The approval comes after an independent panel to the FDA urged the agency to reject the Biogen drug.
Source: TODAYshow - 🏆 389. / 55 Read more »

The differences are clear Biden represents contradictory statements, virus secrecy, redacted emails and indecision while Trump simply pushes for COVID reparations from China. An important contrast to consider in the next election. Wow I thought we were just supposed to “follow the science” and blindly accept the FDA’s decisions? Bitcoin is the most profitable online investment if only you trade with a professional, I advise you to invest in a professional trading and winning strategies. Dm now to setup an investment plan and start earning massively like other Investors cryptoworld
Source: USATODAY - 🏆 100. / 63 Read more »